133 related articles for article (PubMed ID: 25429644)
21. Mean heart dose-based normal tissue complication probability model for pericardial effusion: a study in oesophageal cancer patients.
Fukada J; Fukata K; Koike N; Kota R; Shigematsu N
Sci Rep; 2021 Sep; 11(1):18166. PubMed ID: 34518576
[TBL] [Abstract][Full Text] [Related]
22. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy.
Deek MP; Nagarajan S; Kim S; Ahmed I; Paul S; Scher ED; Listo M; Chen A; Aisner J; Hussain S; Haffty BG; Jabbour SK
Acta Oncol; 2016 Aug; 55(8):1029-35. PubMed ID: 27219912
[TBL] [Abstract][Full Text] [Related]
24. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers.
Mukherjee S; Aston D; Minett M; Brewster AE; Crosby TD
Clin Oncol (R Coll Radiol); 2003 May; 15(3):115-20. PubMed ID: 12801047
[TBL] [Abstract][Full Text] [Related]
25. Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer.
Asakura H; Hashimoto T; Zenda S; Harada H; Hirakawa K; Mizumoto M; Furutani K; Hironaka S; Fuji H; Murayama S; Boku N; Nishimura T
Radiother Oncol; 2010 May; 95(2):240-4. PubMed ID: 20223539
[TBL] [Abstract][Full Text] [Related]
26. Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer.
Everitt S; Duffy M; Bressel M; McInnes B; Russell C; Sevitt T; Ball D
Radiat Oncol; 2016 Feb; 11():20. PubMed ID: 26864559
[TBL] [Abstract][Full Text] [Related]
27. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
28. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer.
Ogino I; Watanabe S; Iwahashi N; Kosuge M; Sakamaki K; Kunisaki C; Kimura K
Strahlenther Onkol; 2016 Jun; 192(6):359-67. PubMed ID: 26884226
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y
Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
[TBL] [Abstract][Full Text] [Related]
31. Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.
Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Fukunaga K; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Nagao T; Ogawa E; Nakano Y
PLoS One; 2020; 15(12):e0244143. PubMed ID: 33370345
[TBL] [Abstract][Full Text] [Related]
32. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
33. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy.
Lin JB; Hung LC; Cheng CY; Chien YA; Lee CH; Huang CC; Chou TW; Ko MH; Lai YC; Liu MT; Chang TH; Lee J; Chen YJ
Radiat Oncol; 2019 May; 14(1):85. PubMed ID: 31126307
[TBL] [Abstract][Full Text] [Related]
36. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
37. Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC.
Niedzielski JS; Wei X; Xu T; Gomez DR; Liao Z; Bankson JA; Lai SY; Court LE; Yang J
Acta Oncol; 2020 Oct; 59(10):1193-1200. PubMed ID: 32678696
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic value of the metabolically active tumour volume].
Paumier A; Marquis A; Trémolières P; Lacombe M; Capitain O; Septans AL; Peyraga G; Gustin P; Vénara A; Ménager É; Visvikis D; Couturier O; Rio E; Hatt M
Cancer Radiother; 2016 Feb; 20(1):24-9. PubMed ID: 26762703
[TBL] [Abstract][Full Text] [Related]
39. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
40. Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer.
Cominos M; Mosleh-Shirazi MA; Tait D; Henrys A; Cornes P
Br J Radiol; 2005 Dec; 78(936):1069-74. PubMed ID: 16352580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
